Page 105 - Fluorescence-guided cancer surgery

Intraoperative guidance in parathyroid surgery 103
Table 1. Patient and surgical characteristics
1 F
2 M
3 M
4 M
5 M
40 34 60 59 21
24.0 PH 31.8 PH 26.8 PH 24.0 PH 27.8 PH by
No 2.70 No 3.03 No 2.80
7.60 PAR right
28.30 PAR left
13.30 PAR left, thymectomy right, hemithyroidectomy left
Parathyroid adenoma
20 25 6; 7 14 23
6 F
7 F
8 F
9 F
67 60 75 44
No 2.72 No 2.89 No 2.72 No 2.88
24.00 PAR left 9.30 PAR right 6.60 PAR left
Parathyroid adenoma Parathyroid adenoma Parathyroid adenoma Reactive lymph nodes
19 20 14 N/A
10 F
11 M
12 F
47 62 70
32.9 PH 30.7 PH 26.8 PH
No 2.62 No 2.66 No 2.78
12.60 PAR left
4.20 PAR left
9.80 PAR left and right, thymectomy
Parathyroid hyperplasia Parathyroid adenoma
6
13 F
52
22.8 PH
No 2.67
8.30 PAR left
Parathyroid hyperplasia
22 resection;
MEN1 25.1 PH 24.8 PH 21.5 PH 28.1 PH
11.80 PAR right, parathyroidectomy left and right, thymectomy
Parathyroid adenoma and normal PTG
PAR right 2.85 No 2.89
6.90 PAR right, thymectomy right
Parathyroid adenoma
15.70 Identi cation normal PTGs, LN resection, thymectomy left
LN, lymph nodes; MEN1, multiple endocrine neoplasia 1 syndrome; N/A, not applicable; PAR, parathyroid adenoma
Abbreviations: BMI,
PH, primary hyperparathyroidism; PTG, parathyroid gland; PTH, parathyroid hormone.
body-mass index;
Parathyroid adenoma
Parathyroid hyperplasia
Parathyroid hyperplasia and normal PTGs
5 28; 20
Patient no. Sex
Age
BMI Disease
Previous treatment
Preoperative calcium, mmol/L
Preoperative PTH, pmol/L
Surgical procedure
Histology
Maximum diameter, mm